The US Food and Drug Administration is moving forward with a web-based survey that it believes will shed light on the prevalence of adverse reactions to cosmetic products attributed to allergens.
Industry stakeholders were skeptical in comments submitted to the FDA, following the agency’s notice of the pilot study, published in...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?